Sampling Prospects in Pharma Industry Discussed in New Cutting-Edge Report Available at MarketPublishers.com

09 Aug 2012 • by Natalie Aster

LONDON – In an age of digital, multi-channel marketing, sampling has remained largely within the domain of sales reps, in spite of evidence that an optimized, centralized multi-channel sampling operation can enhance reach and significantly reduce costs.

The new research report “Sampling: A Key Business Driver in a Multi-channel Environment” worked out by FirstWord has been recently published by Market Publishers Ltd.

Report Details:

Sampling: A Key Business Driver in a Multi-channel Environment
Published: July, 2012
Pages: 53
Price: US$ 395,00

The research report provides in-depth analysis of the major trends in sampling, and a wealth of insights from companies who are pioneering a more intelligent, centralized, and efficibrent approach to sampling.

Key Report Features:

  • overview of the major trends affecting sampling strategies, including the rise in multi-channel operations and increasing acceptance of trial vouchers over physical samples; 
  • breakdown of sample acceptance by therapeutic area; 
  • sample optimisation strategies; 
  • advice to companies debating whether to “build or buy” multi-channel operations; 
  • case study on integrating the sales force into multi-channel sampling; 
  • challenges of the Prescription Drug Marketing Act (PDMA) requirements in a multi-channel environment; 
  • effect of the Sunshine provisions in the Patient Protection and Affordable Care Act (PPACA) on physician acceptance of samples; 
  • examination of the rising importance of vouchers and co-pay coupons.

More new market research reports by the publisher can be found at FirstWord page.

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com